Issued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Jan. 16, 2026 /CNW/ -- Equity Insider News Commentary – The precision medicine sector is undergoing a ...
AbbVie today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback